WO2012114349A1 - An improved process for the preparation of pentosan polysulfate sodium - Google Patents
An improved process for the preparation of pentosan polysulfate sodium Download PDFInfo
- Publication number
- WO2012114349A1 WO2012114349A1 PCT/IN2011/000393 IN2011000393W WO2012114349A1 WO 2012114349 A1 WO2012114349 A1 WO 2012114349A1 IN 2011000393 W IN2011000393 W IN 2011000393W WO 2012114349 A1 WO2012114349 A1 WO 2012114349A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- formula
- compound
- preparation
- pentosan polysulfate
- mixtures
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
- C08B37/0057—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid beta-D-Xylans, i.e. xylosaccharide, e.g. arabinoxylan, arabinofuronan, pentosans; (beta-1,3)(beta-1,4)-D-Xylans, e.g. rhodymenans; Hemicellulose; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/0003—General processes for their isolation or fractionation, e.g. purification or extraction from biomass
Definitions
- the present invention discloses an improved process for the preparation of
- Pentosan Polysulfate Sodium and also disclosed an improved process for the isolation of compound of Formula I.
- Pentosan Polysulfate Sodium is chemically known as ⁇ -D-Xylan, (1-4), 2,3 -bis (hydrogen Sulfate) sodium salt having molecular range of 4000-6000 Dalton and has the following structural formula:
- Pentosan Polysulfate Sodium is a semi-synthetically produced heparin like macromolecular carbohydrate derivative which chemically and structurally resembles glycosaminoglycans. It has anticoagulant and fibrinolytic effects. It is a white odorless powder, slightly hygroscopic and soluble in water upto 50% at pH-6.
- Pentosan Polysulfate is produced from a chemical solution of polysaccharides (e.g. Xylan) extracted from the bark of the beech tree or other plant sources which is then treated with sulfating agents such as chlorosulfonic acid or sulfuryl chloride and an acid. After sulfation, Pentosan Polysulfate is usually treated with sodium hydroxide to yield the sodium salt.
- Pentosan Polysulfate is most commonly used as an oral formulation to treat interstitial cystitis in humans and as an injectable drug to treat osteoarthritis in companion animals. It has also been used for treatment of hematomes, hemarrohoids, frostbites, burns and multiparameter illnesses such as thrombosis and athereosclerosis.
- Pentosan Polysulfate is disclosed in US patent no. 2689848.
- the same patent disclosed the process for the production of salts of sulfuric ester of xylan, the steps comprising oxidizing the aqueous solution of the a salt of sulfuric acid ester of highly polymeric xylan in an aqueous solution of H 2 0 2 and H 2 S0 4 to depolymerize such highly polymeric xylan ester partially, dialyzing the depolymerized product and fractioning an aqueous mixture of the dialyzate with an organic water miscible solvent to obtain a fraction having a ZD value between 0.0030 and 0.015 (The value of ZD is proportional to the degree of polymerization and consequently, serves as an index of the molecular weight or length of the chain of the xylan sulphuric acid esters) and sulfur content of 13.5 to 17%.
- the process as disclosed therein does not describe about the molecular weight of product after getting step-2 or even of final
- WO2008107906 disclosed process for the preparation of Pentosan Polysulfate and an amorphous form of Pentosan Polysulfate sodium with molecular weight of about 3000 to 10000 Dalton.
- WO 2009047699 also described a process for the preparation of an amorphous form of Pentosan Polysulfate Sodium comprising steps of dissolving crude pentosan polysulfate sodium having a molecular weight of 4000 to 6000 Dalton in water (step I) followed by spray drying the solution to obtain amorphous Pentosan Polysulfate Sodium.
- Pentosan Polysulfate Sodium Formula (I) by diluting the aqueous solution with excess of water followed by DiaAlteration through membrane system and isolation of resulting mixture provides high yield with desired molecular weight of 4000-6000 Dalton.
- An object of the present invention is to provide an improved process for preparing Pentosan Polysulfate Sodium.
- It a further object of the present invention to provide a process for purification of Pentosan Polysulfate Sodium using suitable technique.
- It a further object of the present invention to provide an improved process for isolation of Pentosan Polysulfate Sodium using suitable solvents.
- an improved process for preparing Pentosan Polysulfate Sodium of Formula (I), comprising steps of: i) reacting xylan with chlorosulfonic acid in the presence of pyridine followed by addition of alkali in the presence of alcoholic solvent to obtain sodium salt of sulfuric acid ester of xylan. ii) depolymerizing the salt of sulfuric acid ester of xylan with the mixture of H 2 S0 4 and an oxidizing agent to obtain depolymerized crude Pentosan Polysulfate Sodium of Formula (IV)
- the invention provides a process for the preparation of Pentosan Polysulfate sodium of Formula (I) as depicted following steps:
- the steps comprises:
- the suitable solvent used in step-(i) may be selected from (Q-C5) alcohols such as methanol, ethanol, propanol, isopropanol, butanol or mixtures thereof.
- the suitable alkali used in step-(i) is selected from alkali metal salt of carbonates, bicarbonates, hydroxide or mixtures thereof.
- the suitable oxidizing agent used in step-(ii) may be selected from peroxides such as hydrogen peroxides and the like; halogenated oxidizing agents such as sodium hypochlorite, sodiumhypobromide & the like; metallic oxidizing reagents such as osmium tetraoxide, chromates, permanganates, tungestates & the like; periodic acids or salts of periodic acids such as sodium metaperiodate, potassium metaperiodate & the likes either independently or in a suitable mixtures thereof.
- peroxides such as hydrogen peroxides and the like
- halogenated oxidizing agents such as sodium hypochlorite, sodiumhypobromide & the like
- metallic oxidizing reagents such as osmium tetraoxide, chromates, permanganates, tungestates & the like
- periodic acids or salts of periodic acids such as sodium metaperiodate, potassium metaperiodate & the likes
- Suitable diafiltration membranes as are known in the art may be used.
- the diafiltration can be done continuously or discontinuously. Such techniques are well within the ability of a skilled person.
- the suitable membrane system in the filtration step as discussed herein is carried out by using pure flow-U30S ultra filtration membrane.
- This advanced thin film composite ultra filtration membrane has a filtration range of less than 4 KD, preferably 1 D - 4 KD and more preferably 2.8 KD nominal MWCO (Molecular wt. cut off). It removes most of bivalent ions, inorganic salts and unreacted low molecules of solute.
- the suitable solvent for isolation used in step-(iv) may be selected from hydrocarbons such as toluene, xylene, n-heptane, cyclohexane, n-hexane; nitriles such as acetonitrile, propionitrile; (Q to C 5 ) alcohols such as methanol, ethanol, isopropanol and the like; ketones such as acetone, methyl ethyl ketones, methyl isobutyl ketones & the like; amides such as ⁇ , ⁇ -dimethyl acetamides, dimethyl formamide N-methyl-2- pyrrolidinone and the likes either independently or suitable mixtures thereof.
- hydrocarbons such as toluene, xylene, n-heptane, cyclohexane, n-hexane
- nitriles such as acetonitrile, propionitrile
- (Q to C 5 ) alcohols
- the present invention also encompasses a process for the purification of compound of formula (IV).
- Purification of compound of the Formula (IV) followed by Diafilteration through suitable membrane system removes most of bivalent ions, inorganic salts and unreacted low molecules of solute. So, one of the significance of the present process by using the purification technique is to get the desired molecular weight of pure compound of Formula (I) in a pure form.
- Chlorosulfonic acid (350 g) was added slowly in pyridine (870 g) at 25 to 60°C.
- reaction mixture was stirred for next 4-6 hours, adjust pH 6 to 7 with dilute acetic acid.
- the mass was filtered and collected aqueous solution for next step (Diafilteration) without isolation of product.
- GPC average molecular weight 3500 to 6000 D.
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Materials Engineering (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Sustainable Development (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Abstract
The present invention relates to provide an improved process of preparation of Pentosan Polysulfate Sodium of Formula (I) comprising a step of purifying the depolymerized aqueous solution by diluting with excess of water followed by diafiltration through membrane system.
Description
AN IMPROVED PROCESS FOR THE PREPARATION OF PENTOSAN
POLYSULFATE SODIUM
FIELD OF INVENTION
The present invention discloses an improved process for the preparation of
Pentosan Polysulfate Sodium and also disclosed an improved process for the isolation of compound of Formula I.
Pentosan Polysulfate Sodium (Formula I)
BACKGROUND OF THE INVENTION
Pentosan Polysulfate Sodium is chemically known as β-D-Xylan, (1-4), 2,3 -bis (hydrogen Sulfate) sodium salt having molecular range of 4000-6000 Dalton and has the following structural formula:
Pentosan Polysulfate Sodium
Pentosan Polysulfate Sodium is a semi-synthetically produced heparin like macromolecular carbohydrate derivative which chemically and structurally resembles glycosaminoglycans. It has anticoagulant and fibrinolytic effects. It is a white odorless powder, slightly hygroscopic and soluble in water upto 50% at pH-6.
Pentosan Polysulfate is produced from a chemical solution of polysaccharides (e.g. Xylan) extracted from the bark of the beech tree or other plant sources which is then treated with sulfating agents such as chlorosulfonic acid or sulfuryl chloride and an acid. After sulfation, Pentosan Polysulfate is usually treated with sodium hydroxide to yield the sodium salt. Pentosan Polysulfate is most commonly used as an oral formulation to treat interstitial cystitis in humans and as an injectable drug to treat osteoarthritis in companion animals. It has also been used for treatment of hematomes,
hemarrohoids, frostbites, burns and multiparameter illnesses such as thrombosis and athereosclerosis.
Pentosan Polysulfate is disclosed in US patent no. 2689848. The same patent disclosed the process for the production of salts of sulfuric ester of xylan, the steps comprising oxidizing the aqueous solution of the a salt of sulfuric acid ester of highly polymeric xylan in an aqueous solution of H202 and H2S04 to depolymerize such highly polymeric xylan ester partially, dialyzing the depolymerized product and fractioning an aqueous mixture of the dialyzate with an organic water miscible solvent to obtain a fraction having a ZD value between 0.0030 and 0.015 (The value of ZD is proportional to the degree of polymerization and consequently, serves as an index of the molecular weight or length of the chain of the xylan sulphuric acid esters) and sulfur content of 13.5 to 17%. The process as disclosed therein does not describe about the molecular weight of product after getting step-2 or even of final product. The patent only characterized the final product by ZD value and sulfur content.
US 4713373 disclosed novel xylan sulfates having a sulfation degree between
1.5 and 2.0 and an apparent molecular weight from about 2000-5000.The process disclosed the ultra filtration technique for the preparation of above claimed compound. Moreover the process does not provide the desired pentosan polysulfate sodium with molecular weight of 4000 to 6000 Dalton specifically.
WO2008107906 disclosed process for the preparation of Pentosan Polysulfate and an amorphous form of Pentosan Polysulfate sodium with molecular weight of about 3000 to 10000 Dalton. In the process xylan treated with chlorosulfonic acid in the presence of pyridine followed by addition of alkali in the presence of alcoholic solvent to obtain salt of sulfuric acid ester of xylan. Oxidizing the salt with the mixture of H2S04 and 30% ¾02 to obtain depolymerized crude pentosan polysulfate Sodium of Formula (I). Purifying depolymerized crude pentosan polysulfate sodium by filtration through NF membrane system. Lyophilizing the product to obtain amorphous form of pentosan polysulfate sodium. Moreover the process does not provide the desired pentosan polysulfate sodium with molecular weight of 4000 to 6000 Dalton specifically WO2009087581 disclosed process for the preparation of Pentosan Polysulfate or salt thereof comprising a step of treating xylan with chlorosulfonic acid in the presence of picoline followed by addition of alkali in the presence of alcoholic solvent to obtain salt of sulfuric acid ester of xylan. Oxidizing the salt with the mixture of
H2S04 and 30% H202 to obtain depolymerized crude pentosan polysulfate of Formula (I) or its salt, purifying depolymerized crude pentosan polysulfate of Formula (I) or its salt by filtration through NF membrane system.
WO 2009047699 also described a process for the preparation of an amorphous form of Pentosan Polysulfate Sodium comprising steps of dissolving crude pentosan polysulfate sodium having a molecular weight of 4000 to 6000 Dalton in water (step I) followed by spray drying the solution to obtain amorphous Pentosan Polysulfate Sodium.
Thus the prior processes described above for the preparation of Pentosan Polysulfate Sodium is tedious and costly. So, there is a need in the art to develop a process for preparation of Pentosan Polysulfate Sodium which provides good yield, simple, convenient, economical and easily applicable at an industrial scale.
We herein disclosed a purification method of Pentosan Polysulfate Sodium Formula (I) by diluting the aqueous solution with excess of water followed by DiaAlteration through membrane system and isolation of resulting mixture provides high yield with desired molecular weight of 4000-6000 Dalton.
OBJECTS OF THE INVENTION
An object of the present invention is to provide an improved process for preparing Pentosan Polysulfate Sodium.
It a further object of the present invention to provide a process for purification of Pentosan Polysulfate Sodium using suitable technique.
It a further object of the present invention to provide an improved process for isolation of Pentosan Polysulfate Sodium using suitable solvents.
The above and other embodiments are further described in the following paragraphs.
DETAILED DESCRD7TION
The above and other objects of the present invention are achieved by an improved process for preparing Pentosan Polysulfate Sodium of Formula (I), comprising steps of: i) reacting xylan with chlorosulfonic acid in the presence of pyridine followed by addition of alkali in the presence of alcoholic solvent to obtain sodium salt of sulfuric acid ester of xylan.
ii) depolymerizing the salt of sulfuric acid ester of xylan with the mixture of H2S04 and an oxidizing agent to obtain depolymerized crude Pentosan Polysulfate Sodium of Formula (IV)
iii) purifying the depolymerized aqueous solution of Formula (IV) by diluting with excess of water followed by diafiltration through suitable membrane system
iv) isolation of the product obtained in the step-(iii) from suitable solvents to obtain pure Pentosan Polysulfate Sodium of Formula (I)
Accordingly, the invention provides a process for the preparation of Pentosan Polysulfate sodium of Formula (I) as depicted following steps:
The steps comprises:
i) reacting xylan with chlorosulfonic acid in the presence of pyridine followed by addition of suitable alkali in the presence of suitable alcoholic solvent to obtain sodium salt of sulfuric acid e
Formula-Ill
The suitable solvent used in step-(i) may be selected from (Q-C5) alcohols such as methanol, ethanol, propanol, isopropanol, butanol or mixtures thereof. The most preferably is methanol.
The suitable alkali used in step-(i) is selected from alkali metal salt of carbonates, bicarbonates, hydroxide or mixtures thereof. The most preferably is sodium hydroxide.
ii) reacting the compound of Formula (III) with a mixture of suitable oxidizing agents and H2S04 to obtain the depolymerized compound of Formula (IV)
Formula-IV
Average M.W. 3500-6000 D
The suitable oxidizing agent used in step-(ii) may be selected from peroxides such as hydrogen peroxides and the like; halogenated oxidizing agents such as sodium hypochlorite, sodiumhypobromide & the like; metallic oxidizing reagents such as osmium tetraoxide, chromates, permanganates, tungestates & the like; periodic acids or salts of periodic acids such as sodium metaperiodate, potassium metaperiodate & the likes either independently or in a suitable mixtures thereof.
iii) purifying the depolymerized aqueous solution of Formula (IV) obtained in step-(ii) by diluting with excess of water to 0.25 - 2.5 % followed by Dia-filteration through suitable membrane system to obtain compound of formula (V)
Average M.W. 3500-6000 D
Formula-V
Average M.W. 4000-6000 D
Suitable diafiltration membranes as are known in the art may be used. The diafiltration can be done continuously or discontinuously. Such techniques are well within the ability of a skilled person. For the present invention the suitable membrane
system in the filtration step as discussed herein is carried out by using pure flow-U30S ultra filtration membrane. This advanced thin film composite ultra filtration membrane has a filtration range of less than 4 KD, preferably 1 D - 4 KD and more preferably 2.8 KD nominal MWCO (Molecular wt. cut off). It removes most of bivalent ions, inorganic salts and unreacted low molecules of solute.
iv) isolation of the compound of Formula (V) in suitable solvent to obtain compound of Formula (I)
Formula-I
Average M.W. 4000-6000 D
The suitable solvent for isolation used in step-(iv) may be selected from hydrocarbons such as toluene, xylene, n-heptane, cyclohexane, n-hexane; nitriles such as acetonitrile, propionitrile; (Q to C5) alcohols such as methanol, ethanol, isopropanol and the like; ketones such as acetone, methyl ethyl ketones, methyl isobutyl ketones & the like; amides such as Ν,Ν-dimethyl acetamides, dimethyl formamide N-methyl-2- pyrrolidinone and the likes either independently or suitable mixtures thereof.
Thus, the present invention also encompasses a process for the purification of compound of formula (IV). Purification of compound of the Formula (IV) followed by Diafilteration through suitable membrane system removes most of bivalent ions, inorganic salts and unreacted low molecules of solute. So, one of the significance of the present process by using the purification technique is to get the desired molecular weight of pure compound of Formula (I) in a pure form.
The process of the present invention is further described by the following non- limiting examples, which provides the preferred mode of carrying out the process of the present invention. It is to be appreciated that several alterations, modifications, optimizations of the processes described herein are well within the scope of a person
skilled in the art should be construed to be within the scope of the present inventive concept as is disclosed anywhere in the specification.
Exam pie- 1
Process for the preparation of Pentosan Polysulfate Sodium (Formula III)
Chlorosulfonic acid (350 g) was added slowly in pyridine (870 g) at 25 to 60°C.
The solution was maintained for 15 minutes. Xylan (100 g) was added at 25-60 °C. The reaction mixture was heated at 80-85°C. The reaction mixture was stirred for next 2-4 hours at 80-85°C. The reaction mixture was cool down to 55-60 °C. Methanol (1600 mL) was slowly added. The mass was cooled at 25-35°C and stirred for 1-2 hours. The solid mass was filtered and washed with methanol. The wet cake was taken into RO (Reverse Osmosis) water and stirred to get clear solution. Previously prepared sodium chlorite (28 g) and Cone, hydrochloric acid (22 mL) solution was added into above solution in 30 minutes and stirred for 4-6 hours and quenched into methanolic sodium hydroxide solution and was stirred for 1-3 hours at 25-35°C. To the reaction mixture acetic acid was added to get pH 6 to 7 and stirred with 1 hour. The solid mass was filtered and washed with methanol. The wet cake was taken into methanol (500 mL) and stirred for next 1 hour. The solid mass was filtered and washed with methanol. The wet solid was dried at 50-55°C under vacuum to get 180 to 240 g product). GPC average molecular weight. 30000 to 50000D (Yield: 70 to 94 %).
Examp e-2
Process for the preparation of Pentosan Polysulfate Sodium (Formula IV)
In a 2-lit R. B. Flask water (500 mL) and Pentosan Polysulfate Sodium (Formula III) (200 g) were added. The solution was heated to 95-100°C. The solution of 25 to 33% hydrogen peroxide (15.85 g), sulfuric acid (0.9 g) and RO water (100 mL) was added in 30 minutes at 95-100 °C. The reaction mixture was further stirred at 95- 100°C next 4 to 7 hours (till one achieves average M.W. 3500 to 6000 D). The reaction mixture was cooled to 15 to 20°C. Activated carbon (5.0 g) and 30% sodium hydroxide solution was added in to reaction mass below 30°C. The reaction mixture was stirred for next 4-6 hours, adjust pH 6 to 7 with dilute acetic acid. The mass was filtered and collected aqueous solution for next step (Diafilteration) without isolation of product. GPC average molecular weight 3500 to 6000 D.
Example-3
Process for the preparation of Pentosan Polysulfate Sodium (Formula V)
In a 50-lit HDPE Tank equipped with mechanical stirrer, RO water (40 L) and Pentosan Polysulfate Sodium (Formula IV) solution obtained in example-2 above, (approx 1200 mL) were charged. The reaction mixture was stirred for 15 minutes. The solution was passed through 2.8 D membrane and removed free sulfate and lower molecular weight product were collected in permeate HDPE Tank. After removing sulfate salt and lower molecular weight product, solution was passed through RO (Reverse Osmosis) membrane to get concentrated solution by removing the excess of water from the solution. Finally the product in retanate (approx. 7 to 8% solution, 500 to 550 mL) was; used for next step without isolation of product. GPC average molecular weight 4000 to 6000 D.
Example-4
Process for the preparation of Pentosan Polysulfate Sodium (Formula I)
In a 2-lit R. B. Flask Pentosan Polysulfate Sodium (Formula V) obtained in example-3 above (550 mL) was added. Water was distilled out below 65°C under vacuum. Finally leaving behind approximately 130 to 150 mL residual product. The reaction mixture was cooled to 25 to 30°C. Methanol (800 mL) was added slowly over 3-4 hours. The solid mass was stirred for next 3 hours. The solid was filtered and washed with methanol. The product was dried at 60 to 65°C for 10 hours to get 60 to 70 g pure product. GPC average molecular weight 4000 to 6000 D. (Yield: 90 to 98 %) Further aspect of the present invention is to provide an improved process of isolation method for preparation of Pentosan polysulfate Sodium of Formula (I)
Example-5
To a 2-lit R. B. Flask Pentosan Polysulfate Sodium (80 g) and Cyclohexane (800 mL) was charged. The solution was heated at 80°C for 1 hour. Cyclohexane (400 mL) was distilled at 80 to 85°C. Solution was cooled down to 25-35°C and stirred for 30 min. The solid product was filtered and washed with Cyclohexane. The wet solid was dried at 65 to 75°C to get product 72 to 80 g (Yield: 90 to 100 %).
Example -6
To a 50 mL R. B. flask Pentosan Polysulfate Sodium (2 g) was dissolved in RO water under stirring at 25-35°C. Acetonitrile was added dropwise in 1 hour. The reaction mixture was stirred at 25-35°C for next 2 hours. The solid product was filtered and washed with Acetonitrile. The wet solid was dried at 65 to75°C to get product 1.70 g (Yield: 85 %).
Example - 7
To a 50 mL R. B. flask Pentosan Polysulfate Sodium (2 g) was dissolved in RO water under stirring at 25-35°C. Acetone was added dropwise in 1 hour. The reaction mixture was stirred at 25-35°C for next 2 hours. The solid product was filtered and washed with Acetone. The wet solid was dried at 65 to75°C to get product 1.78 g. (Yield: 89 %).
Example - 8
To a 50 mL R. B. flask Pentosan Polysulfate Sodium (2 g) was dissolved in RO water under stirring at 25-35°C. Ν,Ν-dimethyl acetamide was added dropwise in 1 hour. The reaction mixture was stirred at 25-35°C for next 2 hours. The solid product was filtered and washed with N, N-dimethyl acetamide. The wet solid was dried at 65 to75°C to get product 1.62 g (Yield: 81 %).
Example - 9
To a 50 mL R. B. Flask Pentosan Polysulfate Sodium (2 g) was dissolved in RO water under stirring at 25-35°C. Ethanol was added dropwise in 1 hour. The reaction mixture was stirred at 25-35°C for next 2 hours. The solid product was filtered and washed with ethanol. The wet solid was dried at 65 to75°C to get product 1.82 g. (Yield: 91 %).
Example - 10
To a 50 mL R. B. flask Pentosan Polysulfate Sodium (2 g) was dissolved in RO water under stirring at 25-35°C. Isopropanol was added dropwise in 1 hour. The reaction mixture was stirred at 25-35°C for next 2 hours. The solid product was filtered and washed with isopropanol. The wet solid was dried at 65 to75°C to get product 1.69 g (Yield: 84.5 %).
Example - 11
To a 50 mL R. B. flask Pentosan Polysulfate Sodium (2 g) was dissolved in RO water under stirring at 25-35°C. 1-propanol was added dropwise in 1 hour. The reaction mixture was stirred at 25-35°C for next 2 hours. The solid product was filtered and washed with 1-propanol. The wet solid was dried at 65 to75°C to get product 1.83 g (Yield: 91.5 %).
Claims
laim:
A process for the preparation of Pentosan Polysulfate Sodium of Formula (I) comprising steps of:
i) reacting xylan with chiorosulfonic acid in the presence of pyridine followed by addition of suitable alkali in the presence of suitable alcoholic solvent to obtain sodium salt of sulfuric acid ester of xylan Formula (III)
Formula-Ill
ϋ) reacting the compound of Formula (III) with a mixture of suitable oxidizing agents and H2S04 to obtain the depolymerized compound of Formula (IV)
Formula-IV
Average M.W. 3500-6000 D
iii) purifying the depolymerized aqueous solution of Formula (IV) obtained in step (ii) by diluting with excess of water followed by diafiltration through suitable membrane system to obtain compound of Formula (V)
Average M.W. 3500-6000 D
Formula-V
Average M.W. 4000-6000 D
iv) isolation of the compound of Formula (V) in suitable solvent to obtain compound of Formula (I)
Formula-I
Average M.W. 4000-6000 D
2. The process for the preparation of compound of Formula (I) as claimed in claim 1 step (i), wherein the suitable alkali is selected from alkali metal salt of carbonates, bicarbonates, hydroxide or mixtures thereof.
3. The process for the preparation of compound of Formula (I) as claimed in claim 1 step (i), wherein the suitable solvent selected from alcohols such as methanol, ethanol, propanol, isopropanol, butanol or mixtures thereof.
4. The process for the preparation of compound of Formula (I) as claimed in claim 1 step (ii), wherein the suitable oxidizing agent selected from peroxides, halogenated oxidizing agents, metallic oxidizing reagents, periodic acids or salts of periodic acids or in suitable mixtures thereof.
5. The process for the preparation of compound of Formula (I) as claimed in claim 1 step (iii), wherein the purification of depolymerized aqueous solution of formula (IV) obtain in step-2 by diluting with excess of water to 0.25 - 2.5 % followed by diafiltration membrane system.
6. The process for the preparation of compound of Formula (I) as claimed in claim 1 step (iii), wherein the diafiltration membrane is having a filtration capacity of less than 4 KD, preferably 1 KD - 4 KD.
7. The process as claimed in claim 6, wherein the diafiltration membrane having a filtration capacity of preferably 2.8 KD.
8. The process for the preparation of compound of Formula (I) as claimed in claim 1 step (iv), wherein the suitable solvent for isolation is selected from hydrocarbons, nitriles, (Ci to C5) alcohols, ketones, amides and suitable mixtures thereof.
9. The process as claimed in claim 8, wherein the hydrocarbons are selected from toluene, xylene, n-heptane, cyclohexane, n-hexane and suitable mixtures thereof.
10. The process as claimed in claim 8, wherein the nitriles are selected from acetonitrile, propionitrile and suitable mixtures thereof.
11. The process as claimed in claim 8, wherein the alcohols are selected from methanol, ethanol, isopropanol, butanol and suitable mixtures thereof.
12. The process as claimed in claim 8, wherein the ketones are selected from acetone, methyl ethyl ketones, methyl isobutyl ketones and suitable mixtures thereof.
13. The process as claimed in claim 8, wherein the amides are selected from N,N- dimethyl acetamides, dimethylformamide N-methyl-2-pyrrolidinone and suitable mixtures thereof.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN499/MUM/2011 | 2011-02-23 | ||
| IN499MU2011 | 2011-02-23 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO2012114349A1 true WO2012114349A1 (en) | 2012-08-30 |
Family
ID=44532997
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/IN2011/000393 Ceased WO2012114349A1 (en) | 2011-02-23 | 2011-06-13 | An improved process for the preparation of pentosan polysulfate sodium |
Country Status (1)
| Country | Link |
|---|---|
| WO (1) | WO2012114349A1 (en) |
Cited By (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103130917A (en) * | 2013-03-21 | 2013-06-05 | 苏州鸿洋医药科技有限公司 | Preparation method of pentosan polysulfuric acid and salt thereof |
| ITMI20130112A1 (en) * | 2013-01-24 | 2014-07-25 | Chemi Spa | QUALIFICATION METHOD OF PENTOSAN POLYPHOSPHATE PREPARATIONS, ITS RAW MATERIALS AND PRODUCTION PROCESSES |
| WO2016191698A1 (en) * | 2015-05-27 | 2016-12-01 | Vanguard Therapeutics, Inc. | Pentosan polysulfate sodium for the treatment of sickle cell disease |
| WO2018159580A1 (en) * | 2017-02-28 | 2018-09-07 | 王子ホールディングス株式会社 | Pentosan polysulfate, pharmaceutical composition and anticoagulant |
| CN109793751A (en) * | 2019-01-15 | 2019-05-24 | 广西壮族自治区中国科学院广西植物研究所 | Application of arabinoxylan sulfonate in preparation of medicine for treating osteoarthritis |
| WO2021050320A1 (en) * | 2019-09-09 | 2021-03-18 | Harrow Ip, Llc | Pharmaceutical compositions comprising heparinoids and methods for preparing thereof |
| US11278485B2 (en) | 2017-05-31 | 2022-03-22 | Oji Holdings Corporation | Moisturizing topical preparation |
| US11286272B2 (en) | 2016-08-31 | 2022-03-29 | Oji Holdings Corporation | Production method for acidic xylooligosaccharide, and acidic xylooligosaccharide |
| US11312790B2 (en) | 2016-08-31 | 2022-04-26 | Oji Holdings Corporation | Production method for pentosan polysulfate |
| US11344570B2 (en) | 2017-12-20 | 2022-05-31 | Oji Holdings Corporation | Pentosan polysulfate and medicine containing pentosan polysulfate |
| US11390693B2 (en) | 2017-09-12 | 2022-07-19 | Oji Holdings Corporation | Pentosan polysulfate and method for producing pentosan polysulfate |
Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2689848A (en) | 1951-02-06 | 1954-09-21 | Wander Ag Dr A | Salts of sulfuric acid esters of xylan |
| US4699900A (en) * | 1983-03-24 | 1987-10-13 | Sanofi S.A. | Xylane sulfates, process for their preparation, and anti-thrombosis and hypolipemic activity thereof |
| US4713373A (en) | 1984-11-07 | 1987-12-15 | Sanofi S.A. | Xylan sulfates of low molecular weight, process for their preparation and medicaments containing them |
| US5145841A (en) * | 1987-03-19 | 1992-09-08 | Arthropharm Pty. Limited | Anti-inflammatory compounds and compositions |
| WO2008107906A1 (en) | 2007-03-06 | 2008-09-12 | Alembic Limited | Process for the preparation of pentosan polysulfate or salts thereof |
| WO2009047699A1 (en) | 2007-10-10 | 2009-04-16 | Alembic Limited | An improved process for the preparation of an amorphous form of pentosan polysulfate or salts thereof |
| WO2009087581A1 (en) | 2008-01-04 | 2009-07-16 | Alembic Limited | An improved process for the preparation of pentosan polysulfate or salts thereof |
| WO2010000013A1 (en) * | 2008-07-04 | 2010-01-07 | Parnell Laboratories (Aust) Pty Ltd | A sulfated polysaccharide compound and the preparation and use thereof |
-
2011
- 2011-06-13 WO PCT/IN2011/000393 patent/WO2012114349A1/en not_active Ceased
Patent Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2689848A (en) | 1951-02-06 | 1954-09-21 | Wander Ag Dr A | Salts of sulfuric acid esters of xylan |
| US4699900A (en) * | 1983-03-24 | 1987-10-13 | Sanofi S.A. | Xylane sulfates, process for their preparation, and anti-thrombosis and hypolipemic activity thereof |
| US4713373A (en) | 1984-11-07 | 1987-12-15 | Sanofi S.A. | Xylan sulfates of low molecular weight, process for their preparation and medicaments containing them |
| US5145841A (en) * | 1987-03-19 | 1992-09-08 | Arthropharm Pty. Limited | Anti-inflammatory compounds and compositions |
| WO2008107906A1 (en) | 2007-03-06 | 2008-09-12 | Alembic Limited | Process for the preparation of pentosan polysulfate or salts thereof |
| WO2009047699A1 (en) | 2007-10-10 | 2009-04-16 | Alembic Limited | An improved process for the preparation of an amorphous form of pentosan polysulfate or salts thereof |
| WO2009087581A1 (en) | 2008-01-04 | 2009-07-16 | Alembic Limited | An improved process for the preparation of pentosan polysulfate or salts thereof |
| WO2010000013A1 (en) * | 2008-07-04 | 2010-01-07 | Parnell Laboratories (Aust) Pty Ltd | A sulfated polysaccharide compound and the preparation and use thereof |
Cited By (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11242412B2 (en) | 2013-01-24 | 2022-02-08 | Chemi S.P.A. | Method for the qualification of preparations of pentosan polysulfate, raw materials and production processes thereof |
| ITMI20130112A1 (en) * | 2013-01-24 | 2014-07-25 | Chemi Spa | QUALIFICATION METHOD OF PENTOSAN POLYPHOSPHATE PREPARATIONS, ITS RAW MATERIALS AND PRODUCTION PROCESSES |
| WO2014114723A1 (en) * | 2013-01-24 | 2014-07-31 | Chemi S.P.A. | Method for the qualification of preparations of pentosan polysulfate, raw materials and production processes thereof |
| US10407515B2 (en) | 2013-01-24 | 2019-09-10 | Chemi S.P.A. | Method for the qualification of preparations of pentosan polysulfate, raw materials and production processes thereof |
| CN103130917A (en) * | 2013-03-21 | 2013-06-05 | 苏州鸿洋医药科技有限公司 | Preparation method of pentosan polysulfuric acid and salt thereof |
| WO2016191698A1 (en) * | 2015-05-27 | 2016-12-01 | Vanguard Therapeutics, Inc. | Pentosan polysulfate sodium for the treatment of sickle cell disease |
| US11312790B2 (en) | 2016-08-31 | 2022-04-26 | Oji Holdings Corporation | Production method for pentosan polysulfate |
| US11286272B2 (en) | 2016-08-31 | 2022-03-29 | Oji Holdings Corporation | Production method for acidic xylooligosaccharide, and acidic xylooligosaccharide |
| WO2018159580A1 (en) * | 2017-02-28 | 2018-09-07 | 王子ホールディングス株式会社 | Pentosan polysulfate, pharmaceutical composition and anticoagulant |
| KR102520754B1 (en) | 2017-02-28 | 2023-04-11 | 오지 홀딩스 가부시키가이샤 | Polypentoic acid, pharmaceutical composition and anticoagulant |
| CN110325553B (en) * | 2017-02-28 | 2021-10-08 | 王子控股株式会社 | Pentosan polysulfate, pharmaceutical composition and anticoagulant |
| KR20190120216A (en) * | 2017-02-28 | 2019-10-23 | 오지 홀딩스 가부시키가이샤 | Polysulfate pentosan, pharmaceutical compositions and anticoagulants |
| US11274165B2 (en) | 2017-02-28 | 2022-03-15 | Oji Holdings Corporation | Pentosan polysulfate, pharmaceutical composition, and anticoagulant |
| CN110325553A (en) * | 2017-02-28 | 2019-10-11 | 王子控股株式会社 | Pentosan polysulfate, pharmaceutical composition and anticoagulant |
| US11278485B2 (en) | 2017-05-31 | 2022-03-22 | Oji Holdings Corporation | Moisturizing topical preparation |
| US11390693B2 (en) | 2017-09-12 | 2022-07-19 | Oji Holdings Corporation | Pentosan polysulfate and method for producing pentosan polysulfate |
| US11344570B2 (en) | 2017-12-20 | 2022-05-31 | Oji Holdings Corporation | Pentosan polysulfate and medicine containing pentosan polysulfate |
| CN109793751A (en) * | 2019-01-15 | 2019-05-24 | 广西壮族自治区中国科学院广西植物研究所 | Application of arabinoxylan sulfonate in preparation of medicine for treating osteoarthritis |
| CN109793751B (en) * | 2019-01-15 | 2021-02-26 | 广西壮族自治区中国科学院广西植物研究所 | Application of arabinoxylan sulfonate in preparation of medicine for treating osteoarthritis |
| WO2021050320A1 (en) * | 2019-09-09 | 2021-03-18 | Harrow Ip, Llc | Pharmaceutical compositions comprising heparinoids and methods for preparing thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2012114349A1 (en) | An improved process for the preparation of pentosan polysulfate sodium | |
| US20100105889A1 (en) | Process for the preparation of pentosan polysulfate or salts thereof | |
| JPH0558002B2 (en) | ||
| EP0076279B1 (en) | Method for obtaining biologically active mucopolysaccharides of high purity by controlled depolymerization of heparin | |
| CA2501546C (en) | Heparin-derived polysaccharide mixtures, preparation thereof and pharmaceutical compositions containing same | |
| JP2005507438A (en) | Extraction of polysaccharides from vegetables and microbial substances | |
| FR2593801A1 (en) | Process for the preparation of basic zinc carbonate | |
| CN103554303B (en) | A kind of method of purifying cm-chitosan | |
| EP0116251B1 (en) | Process for the depolymerization and sulfation of polysaccharides | |
| EP3724235B1 (en) | Process for the preparation of low molecular weight heparin | |
| WO2003046014A1 (en) | Method for sulphonation of compounds comprising free hydroxyl (oh) groups or primary or secondary amines | |
| JPH04117401A (en) | Production of sulfonated chitosan | |
| US10889654B2 (en) | Acylation process | |
| EP0148057B1 (en) | Chitosan-6-sulphate and process for its preparation | |
| RU2441025C1 (en) | Method of producing low-molecular pectin | |
| JP2009068014A (en) | Water-soluble oxidized chitin and method for producing the same | |
| US7345165B2 (en) | Method for preparing water-soluble free amine chitosan | |
| JP7674376B2 (en) | Method for the direct sulfation of polysaccharides in an ecologically acceptable solvent | |
| FR3079831A1 (en) | PROCESS FOR EXTRACTING OLIGOFUCANS AND ITS APPLICATIONS | |
| JP4954491B2 (en) | Chondroitin sulfation method | |
| RU2546965C1 (en) | Method of obtaining sulphated derivatives of arabinogalactan | |
| JP2003212903A (en) | Method for producing chitosan oxide | |
| RU2441024C1 (en) | Method of producing low-molecular pectin | |
| KR0139615B1 (en) | Production method of 0-carboxymethyl chitin | |
| JP4221925B2 (en) | Method for producing chitin oxide |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 11749557 Country of ref document: EP Kind code of ref document: A1 |
|
| NENP | Non-entry into the national phase |
Ref country code: DE |
|
| 122 | Ep: pct application non-entry in european phase |
Ref document number: 11749557 Country of ref document: EP Kind code of ref document: A1 |